title: The assessment of human organic cation transporter 1 (hOCT1) mRNA expression in patients with chronic myelogenous leukemia is affected by the proportion of different cells types in the analyzed cell population.
authors.forename: Zdenek
authors.initials: Z
authors.lastname: Racil
authors.forename: Filip
authors.initials: F
authors.lastname: Razga
authors.forename: Lucie
authors.initials: L
authors.lastname: Buresova
authors.forename: Tomas
authors.initials: T
authors.lastname: Jurcek
authors.forename: Dana
authors.initials: D
authors.lastname: Dvorakova
authors.forename: Daniela
authors.initials: D
authors.lastname: Zackova
authors.forename: Shira
authors.initials: S
authors.lastname: Timilsina
authors.forename: Petr
authors.initials: P
authors.lastname: Cetkovsky
authors.forename: Jiri
authors.initials: J
authors.lastname: Mayer
mesh_terms: D001549:Benzamides; D016903:Drug Monitoring / Q000379:methods* / Q000592:standards; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000473:pathology*; D007958:Leukocyte Count; D007962:Leukocytes / Q000166:cytology*; D007963:Leukocytes, Mononuclear; D009504:Neutrophils; D027702:Organic Cation Transporter 1 / Q000235:genetics*; D010879:Piperazines / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011743:Pyrimidines / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012333:RNA, Messenger / Q000032:analysis*; D012334:RNA, Neoplasm / Q000032:analysis
chemical_list: D001549:Benzamides; D027702:Organic Cation Transporter 1; D010879:Piperazines; D011743:Pyrimidines; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D000068877:Imatinib Mesylate